Levodrop Hustenstiller (Levodropropizine)

Levodropropizine works peripherally on sensory nerve endings in the airway mucosa. By decreasing the excitability of these nerves, it raises the threshold for the cough reflex, thereby suppressing cough signals before they reach the brainstem. This mechanism avoids the central opioid pathways associated with traditional cough suppressants.

The appropriate dose of Levodrop Hustenstiller is determined by a qualified healthcare professional based on the patient’s age, weight, and clinical condition. Prescribers follow local labeling guidelines and adjust the regimen as needed; patients should follow the specific instructions provided by their doctor or pharmacist.

Safety data for levodropropizine in pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category, so it should only be used if the potential benefit justifies the potential risk. Breastfeeding mothers should consult a healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details, and any necessary import documentation.

Levodrop Hustenstiller contains levodropropizine, a peripheral, non‑opioid antitussive, whereas many traditional cough medicines contain opioid derivatives such as codeine. Levodropropizine offers cough relief without the central sedation, dependence risk, or respiratory depression associated with opioid‑based agents, making it suitable for patients where those effects are undesirable.

Levodrop Hustenstiller should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Levodrop Hustenstiller is taken orally as directed by a healthcare professional. The dosage form is an oral preparation that can be swallowed with or without water. Patients should follow the prescribed schedule and avoid exceeding the recommended frequency.

Serious risks, although rare, include hypersensitivity reactions such as rash, itching, swelling of the face, lips, or tongue, and potential hepatic dysfunction indicated by abnormal liver enzyme levels. Any signs of an allergic reaction or liver issues should prompt immediate medical evaluation.

Levodrop Hustenstiller should be avoided in individuals with known hypersensitivity to levodropropizine or any excipients in the formulation. It is also contraindicated in patients with severe hepatic impairment and should be used with caution in pregnant or breastfeeding women after professional assessment.